TP53 and cancer: Similarly, among p53 mutant cancers 40.7% (22 out of 54) of patients in deprivation groups 1–9 relapsed compared with 80% (8 out of 10) of those in the worst deprivation category (P=0.025, 2FET; OR=6.1(1.4,26.6); power=0.74; and P=0.036, 2FET; OR=5.8(1.1,30.0); power=0.65; respectively).